Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia
- PMID: 704769
Item in Clipboard
Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia
Psychopharmacol Bull.
1978 Oct.
No abstract available
Similar articles
-
Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.Adv Neurol. 1983;37:259-66. Adv Neurol. 1983. PMID: 6134445 No abstract available.
-
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.J Clin Psychiatry. 1984 Jan;45(1):28-30. J Clin Psychiatry. 1984. PMID: 6141157
-
Dopamine agonists in clinical research for new tardive dyskinesia treatments.Mod Probl Pharmacopsychiatry. 1983;21:97-110. doi: 10.1159/000408487. Mod Probl Pharmacopsychiatry. 1983. PMID: 6140637 No abstract available.
-
Animal models of tardive dyskinesia: their use in the search for new treatment methods.Mod Probl Pharmacopsychiatry. 1983;21:5-20. doi: 10.1159/000408479. Mod Probl Pharmacopsychiatry. 1983. PMID: 6140633 Review. No abstract available.
-
Tardive dyskinesia: pathophysiology and animal models.J Clin Psychiatry. 2000;61 Suppl 4:5-9. J Clin Psychiatry. 2000. PMID: 10739324 Review.
Cited by
-
Abnormal involuntary movements: side-effect of neuroleptic drugs.Can Fam Physician. 1982 Jan;28:105-9. Can Fam Physician. 1982. PMID: 21289850 Free PMC article.